Sulfacetamide Sodium Ophthalmic Side Effects
Medically reviewed by Drugs.com. Last updated on Jul 22, 2024.
Applies to sulfacetamide sodium ophthalmic: ophthalmic ointment, ophthalmic solution, ophthalmic suspension.
Side effects include:
Local irritation, transient stinging or burning.
For healthcare professionals
Applies to sulfacetamide sodium ophthalmic: ophthalmic ointment, ophthalmic solution.
General adverse events
The side effects reported most often were local/conjunctival irritation, stinging, and burning.[Ref]
Ocular
- Frequency not reported: Local/conjunctival irritation, stinging, burning, nonspecific conjunctivitis, conjunctival hyperemia, bacterial corneal ulcers, fungal corneal ulcers[Ref]
Hypersensitivity
- Rare (less than 0.1%): Sensitivity reactions
- Frequency not reported: Allergic reactions/hypersensitivity, local hypersensitivity progressing to fatal syndrome resembling systemic lupus erythematosus (SLE)[Ref]
At least 1 case of local hypersensitivity has been reported that progressed to a SLE-like fatal syndrome.[Ref]
Other
- Frequency not reported: Secondary infections[Ref]
Dermatologic
- Frequency not reported: Stevens-Johnson syndrome, toxic epidermal necrolysis[Ref]
Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).
Stevens-Johnson syndrome was reported in a patient with history of blistering drug reaction to an oral sulfonamide.[Ref]
Hematologic
Sulfonamides:
Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).[Ref]
Hepatic
Sulfonamides:
- Frequency not reported: Fulminant hepatic necrosis[Ref]
Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).[Ref]
References
1. "Product Information. Sodium Sulamyd (sulfacetamide sodium ophthalmic)." Schering Corporation
2. Cerner Multum, Inc. "Australian Product Information."
More about sulfacetamide sodium ophthalmic
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Dosage information
- During pregnancy
- Drug class: ophthalmic anti-infectives
- En español
Patient resources
Other brands
Professional resources
- Sulfacetamide monograph
- Sulfacetamide (FDA)
- Sulfacetamide Eye Drops (FDA)
- Sulfacetamide Sodium (FDA)
Related treatment guides
Further information
Sulfacetamide sodium ophthalmic side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.